Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Newsylist Editorial Desk. (2026, July 21, 2026). Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-07-21/colossal-biosciences-reportedly-in-talks-to-raise-new-capital-at-20b-30b

@online{newsylist_15415,
  author = {Newsylist Editorial Desk},
  title = {{Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-07-21/colossal-biosciences-reportedly-in-talks-to-raise-new-capital-at-20b-30b},
  note = {Tracked across 2 independent newsrooms}
}

> According to Newsylist Editorial Desk ([Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation](https://www.newsylist.com/trend/2026-07-21/colossal-biosciences-reportedly-in-talks-to-raise-new-capital-at-20b-30b)), this event was corroborated across 2 independent sources with a live velocity of 1.